All Stories

  1. Replacing statins with PCSK9-inhibitors and delaying treatment until 18 years of age in patients with familial hypercholesterolaemia is not a good idea

    Article • European Heart Journal, March 2016, European Society of Cardiology

    Mr Gisle Langslet

  2. Evolocumab (AMG 145) for primary hypercholesterolemia

    Article • Expert Review of Cardiovascular Therapy, March 2015, Taylor & Francis

    Mr Gisle Langslet